3 ms·
FDA will review Merck’s new Covid treatment ‘as quickly as they possibly can’
- jonathan-adly 5y agoProbably unpopular opinion, but I think the Merck's study[0] data is underwhelming. Only 202 patients without any actual clinical data. Does it prevent hospitalization? Intubations? Lessen severity of illness? All unanswered (study probably underpowered to detect difference). All they told us that it clears the virus by day 5 which is a good start, but perhaps not enough for FDA approval. https://pubmed.ncbi.nlm.nih.gov/34159342/ https://pubmed.ncbi.nlm.nih.gov/34159342/
- jleyank 5y agoThis is Lowe’s second blog on this. You can follow the commentary there: https://www.science.org/content/blog-post/molnupiravir-thor-s-hammer-delivers https://www.science.org/content/blog-post/molnupiravir-thor-...